CONTACT
SITEMAP
Vecata
Venture
Property projects
News
History
Organization
Annual Accounts
Ownership
Portfolio
Network and partners
New Investments
Strategy
Biotech
Medico
IT
Technology
Other
Fluxome Ltd.
LiPlasome Pharma Ltd.
Mirrx Therapeutics Ltd.
QuantiBact Ltd.
ReceptIcon Plc.
Tina Holding Plc.
Chempaq Ltd.
Scandinavian Micro Biodevices Plc.
Vivostat Ltd.
Zoomio Ltd.
Cardlab Plc.
Noiselimit ApS
3D Visiontech Plc.
Columbus E. Plc.
Land for sale (business projects)
Lysholt Park
Be Retainment Park
www.vecata.com
>
Venture
Vecata's ventureportefølje består af selskaber indenfor følgende forretningsområder:
Venture
Network and partners
New Investments
Strategy
Portfolio
Biotech
Fluxome Ltd.
|
LiPlasome Pharma Ltd.
|
Mirrx Therapeutics Ltd.
|
QuantiBact Ltd.
|
ReceptIcon Plc.
|
Tina Holding Plc.
Medico
Chempaq Ltd.
|
Scandinavian Micro Biodevices Plc.
|
Vivostat Ltd.
IT
Zoomio Ltd.
Technology
Cardlab Plc.
|
Noiselimit ApS
|
3D Visiontech Plc.
Other
Columbus E. Plc.
Disclaimer
|
Privacy Policy
VECATA A/S, Dandyvej 19 DK 7100 Vejle | Tlf. +45 72 15 15 00 | Fax. +45 72 15 19 09 | Email: info@vecata.com